l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Trimethylamine N-Oxide and Related Gut

Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism TMAO: how gut microbiota contributes to heart failure Translational Research

SKU: 68010229158 · From creatorsinfotech.com